Patterns of Chinese medicine use in prescriptions for treating Alzheimer’s disease in Taiwan

BackgroundCertain Chinese medicine (CM) herbs and acupuncture may protect against Alzheimer’s disease (AD). However, there is a lack of research regarding the use of CM in patients with AD. The aim of this study was to investigate CM usage patterns in patients with AD, and identify the Chinese herbal formulae most commonly used for AD.MethodsThis retrospective, nationwide, population-based cohort study was conducted using a randomly sampled cohort of one million patients, selected from the National Health Insurance Research Database between 1997 and 2008 in Taiwan. CM use and the top ten most frequently prescribed formulae for treating AD were assessed, including average formulae dose and frequency of prescriptions. Demographic characteristics, including sex, age and insurance level were examined, together with geographic location. Existing medical conditions with the behavioral and psychological symptoms of dementia, and medications associated with CM were also examined. Factors associated with CM use were analyzed by multiple logistic regressions.ResultsThe cohort included 1137 newly diagnosed AD patients, who were given conventional treatment for AD between 1997 and 2008. Among them, 78.2 % also used CM treatments, including Chinese herbal remedies, acupuncture and massage manipulation. Female patients (aOR 1.57 with 95 % CI 1.16–2.13) and those living in urban areas (aOR 3.00 with 95 % CI 1.83–4.90 in the middle of Taiwan) were more likely to use CM. After adjusting for demographic factors, AD patients suffering from the behavioral and psychological symptoms of dementia were more likely to seek CM treatment than those with no symptoms (aOR 2.26 with 95 % CI 1.48–3.43 in patients suffering more than three symptoms). Bu-Zhong-Yi-Qi-Tang and Ji-Sheng-Shen-Qi-Wan were the two formulae most frequently prescribed by CM practitioners for treating AD.ConclusionMost people with AD who consumed herbal products used supplement qi, nourish the blood, and quiet the heart spirit therapy as complementary medicines to relieve AD-related symptoms, in addition to using standard anti-AD treatments.

[1]  K. Hashizume,et al.  American ginseng improves neurocognitive function in senescence‐accelerated mice: Possible role of the upregulated insulin and choline acetyltransferase gene expression , 2012, Geriatrics & gerontology international.

[2]  S. Xiao,et al.  A preliminary analysis of incidence of dementia in Shanghai, China , 1998, Psychiatry and clinical neurosciences.

[3]  H. Ochiai,et al.  Assessment of effects of traditional herbal medicines on elderly patients with weakness using a self‐controlled trial , 2004 .

[4]  F. Sherriff,et al.  Memantine for dementia. , 2005, The Cochrane database of systematic reviews.

[5]  C. K. Liu,et al.  Incidence and subtypes of dementia in southern Taiwan Impact of socio‐demographic factors , 1998, Neurology.

[6]  K. Chu,et al.  An open‐label trial of Korean red ginseng as an adjuvant treatment for cognitive impairment in patients with Alzheimer’s disease , 2008, European journal of neurology.

[7]  G. A. de Souza,et al.  The Use of Herbal Medicine in Alzheimer's Disease—A Systematic Review , 2006, Evidence-based complementary and alternative medicine : eCAM.

[8]  Dong Hyun Kim,et al.  The memory ameliorating effects of INM-176, an ethanolic extract of Angelica gigas, against scopolamine- or Aβ(1-42)-induced cognitive dysfunction in mice. , 2012, Journal of ethnopharmacology.

[9]  Han Yan,et al.  Treating senile dementia with traditional Chinese medicine , 2007, Clinical interventions in aging.

[10]  Yan Liu,et al.  Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3β/tau signaling pathway and the Aβ formation prevention in rats. , 2013, European journal of pharmacology.

[11]  N. Huang,et al.  Utilization patterns of Chinese medicine and Western medicine under the National Health Insurance Program in Taiwan, a population-based study from 1997 to 2003 , 2008, BMC health services research.

[12]  Hui Jin,et al.  Neuroprotective effects of emodin in rat cortical neurons against β-amyloid-induced neurotoxicity , 2010, Brain Research.

[13]  S. Chen,et al.  Anti-aging effects of the traditional Chinese medicine bu-zhong-yi-qi-tang in mice. , 2000, The American journal of Chinese medicine.

[14]  H. Markowitsch,et al.  Amnesic disorders , 2012, The Lancet.

[15]  Jiping Qi,et al.  Inhibition of glycogen synthase kinase‐3β by Angelica sinensis extract decreases β‐amyloid‐induced neurotoxicity and tau phosphorylation in cultured cortical neurons , 2011, Journal of neuroscience research.

[16]  陳方周,et al.  Use frequency of traditional Chinese medicine in Taiwan , 2007 .

[17]  T. Sasada,et al.  Preventive effect of a traditional herbal medicine, Hochu-ekki-to, on immunosuppression induced by surgical stress , 2008, Surgery Today.

[18]  S. Nah,et al.  Ginsenoside Rg3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons. , 2004, Biochemical and biophysical research communications.

[19]  F. Hsu,et al.  Prescription Pattern of Chinese Herbal Products for Diabetes Mellitus in Taiwan: A Population-Based Study , 2013, Evidence-based complementary and alternative medicine : eCAM.

[20]  H. Arai,et al.  Double-Blind , Placebo-Controlled Clinical Trial of the Chinese Herbal Medicine ‘ ‘ Ba Wei Di Huang Wan ’ ’ in the Treatment of Dementia , 2004 .

[21]  Jung-Der Wang,et al.  Prescription Pattern of Chinese Herbal Products for Breast Cancer in Taiwan: A Population-Based Study , 2012, Evidence-based complementary and alternative medicine : eCAM.

[22]  Shun-Ku Lin,et al.  Demographic and medication characteristics of traditional Chinese medicine users among dementia patients in Taiwan: a nationwide database study. , 2015, Journal of ethnopharmacology.

[23]  M. Hsieh,et al.  Studies on the suanzaorentang in the treatment of anxiety , 1985, Psychopharmacology.

[24]  Tzeng-Ji Chen,et al.  Prescriptions of Chinese Herbal Medicine for Constipation Under the National Health Insurance in Taiwan , 2010, Journal of the Chinese Medical Association : JCMA.

[25]  Anne Corbett,et al.  Alzheimer's disease , 2011, The Lancet.

[26]  E. Siemers,et al.  Safety profile of Alzheimer's disease populations in Alzheimer's Disease Neuroimaging Initiative and other 18-month studies , 2012, Alzheimer's & Dementia.

[27]  S. Moebus,et al.  Complementary and alternative medicine: attitudes and patterns of use by German physicians in a national survey. , 2008, Journal of alternative and complementary medicine.

[28]  Stanley C. C. Chik,et al.  Pharmacological Effects of Active Compounds on Neurodegenerative Disease with Gastrodia and Uncaria Decoction, a Commonly Used Poststroke Decoction , 2013, TheScientificWorldJournal.

[29]  Chuan-Fang Lee,et al.  The prescribing of Chinese herbal products in Taiwan: a cross‐sectional analysis of the national health insurance reimbursement database , 2008, Pharmacoepidemiology and drug safety.

[30]  Li Cheng,et al.  Z-ligustilide isolated from Radix Angelicae sinensis ameliorates the memory impairment induced by scopolamine in mice. , 2011, Fitoterapia.

[31]  Alison T. O'Brien,et al.  Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. , 1995, The Gerontologist.

[32]  I. McKeith,et al.  The Prevalence of Autonomic Symptoms in Dementia and Their Association with Physical Activity, Activities of Daily Living and Quality of Life , 2006, Dementia and Geriatric Cognitive Disorders.